Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, talks about the shift in focus that is needed to improve care for patients with asthma.
Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, talks about the shift in focus that is needed to improve care for patients with asthma.
Transcript:
What are some improvements that are needed to improve asthma care?
Winders: Asthma care needs to be improved across the continuum. So, certainly a mild asthma, we've see areas of improvement and things like initial diagnosis and treatment, not prescribing albuterol alone for those mild asthma patients, is a critical effort that we are leading at the Global Allergy and Airways Patient Platform. And then, when we talk about the moderate-to-severe population, it's making sure that there's good inhaler technique, that patients have access to their controller preventer medication in addition to quick relief on a limited basis. But when their disease is uncontrolled or when it's escalating, when the severity level is such that it's not well managed or well controlled, that patients know where to turn and don't have to wait months or even years to get access to that level of specialty care because that's really where they will learn about some of the more targeted personalized treatments that are available for patients today.
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More
Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control
July 3rd 2025Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.
Read More